rss Posted October 1, 2011 Report Share Posted October 1, 2011 Pimecrolimus 1% cream for the treatment of rosacea. J Dermatol. 2011 Sep 28; Authors: Kim MB, Kim GW, Park HJ, Kim HS, Chin HW, Kim SH, Kim BS, Ko HC Abstract Rosacea is a common inflammatory skin disorder; the pathogenesis is unclear. Various treatment options for rosacea are available, but most have limited effectiveness. The aim of this study was to investigate the efficacy and safety of 1% pimecrolimus cream for the treatment of rosacea. Thirty patients with rosacea were enrolled in this 4-week, single-center, open-label study of 1% pimecrolimus cream. Patients were instructed to apply the cream to their faces twice daily and were not permitted to use any other agents. Clinical efficacy was evaluated by a rosacea grading system using photographic documentation and a mexameter. The 26 patients who completed the study experienced significantly reduced rosacea clinical scores from 9.65â€ƒ±â€ƒ1.79 at baseline to 7.27â€ƒ±â€ƒ2.11 at the end of treatment (Pâ€ƒ<â€ƒ0.05). The mexameter-measured erythema index decreased significantly from 418.54â€ƒ±â€ƒ89.56 at baseline to 382.23â€ƒ±â€ƒ80.04 at week 4 (Pâ€ƒ<â€ƒ0.05). The side-effects were mostly transient local irritations. The results of this study suggest that 1% pimecrolimus cream is an effective and well-tolerated treatment for patients with mild to moderate inflammatory rosacea.PMID: 21954922 [PubMed - as supplied by publisher] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=21954922&dopt=Abstract = URL to article Link to comment Share on other sites More sharing options...
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!Register a new account
Already have an account? Sign in here.Sign In Now